RxDoctor Payments Data

Michael Lee, DPM

Foot & Ankle Surgery · Des Moines, IANPI 1366407827

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,637,820 of the $2,121,171 with a category attached, or 77.2%. 20 manufacturers reported payments, led by Trilliant Surgical LLC. at 48.5% of the total. Reporting peaked in 2021 at $1,054,207 and has fallen 88.2% since, to $123,873 in 2025. Among foot & ankle surgery clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,121,171in general payments, 2019–2025

Across 606 payments — averaging $3500.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Trilliant Surgical LLC.$1M
  • Medshape, Inc.$414K
  • Zimmer Biomet$274K
  • Medartis Inc.$208K
  • Nextremity Solutions Inc.$104K
  • Stryker$70K
  • plus $22K from 14 others
$1,287in research payments, 2019–2025

Across 2 payments — averaging $643.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$1K

What the payments were for

  • Royalty or licence$1,637,82077%
  • Consulting fees$413,52519%
  • Travel & lodging$44,7562%
  • Food & beverage$7,7710%
  • Education$17,2931%
  • Gifts$60%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,121,171 in reported general payments places this provider in the 95th percentile of 112 foot & ankle surgery providers in Iowa.

See all foot & ankle surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$65,489
Medicare patients
178
Services billed
630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium116$879
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$731
Methylprednisolone21$122
Cephalexin20$108

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →